FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care
Status:
Active, not recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
Adjuvanted flu vaccine, Fluad, is not immunologically inferior to HD influenza vaccine in
older persons living in long-term care.
Phase:
Phase 4
Details
Lead Sponsor:
David H. Canaday
Collaborators:
Brown University Case Western Reserve University National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) US Department of Veterans Affairs